MAML2 and hemangioendothelioma: Notably, this variant shows more aggressive clinical behavior than conventional composite hemangioendothelioma and is associated with fusions of the PTBP1::MAML2 or EPC1::PCH2 genes; single cases also harbored YAP1::FOXR1 and ARID1B::MAML2 fusions [75].